Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Altamira Therapeutics Ltd banner

Altamira Therapeutics Ltd
NASDAQ:CYTO

Watchlist Manager
Altamira Therapeutics Ltd Logo
Altamira Therapeutics Ltd
NASDAQ:CYTO
Watchlist
Price: 0.1198 USD -60.07% Market Closed
Market Cap: $300k
Write Note Create Alert Ask AI

Altamira Therapeutics Ltd
Investor Relations

Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders.

Show more
Loading
CYTO
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2023
Call Date
Sep 12, 2023
Q2 2023 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Open Transcript
Other Earnings Calls
2023
Q2

Management

Dr. Thomas Meyer Ph.D.
Founder, President, Chairman, CEO & MD
No Bio Available
Mr. Marcel Gremaud CPA
Chief Financial Officer
No Bio Available
Dr. Covadonga Paneda
Chief Operating Officer
No Bio Available
Dr. Samuel A. Wickline M.D.
Chief Scientific Adviser
No Bio Available

Contacts

Address
ZUG
Hamilton
Clarendon House, 2 Church Street
Contacts
+410417297194.0
aurismedical.com
sparklesyt

See Also

Summary
CYTO intrinsic value, competitors valuation, and company profile.
DCF Valuation
CYTO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CYTO stock valuation using valuation multiples.
Wall Street Estimates
CYTO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CYTO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.